Overview

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the tolerability of AVANZ.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
ALK-Abelló A/S